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The c-Jun NH2-terminal protein kinase (JNK) is a mitogen-activated protein kinase (MAPK) involved in the
regulation of various physiological processes. Its activity is increased upon phosphorylation by the MAPK
kinases MKK4 and MKK7. The early embryonic death of mice lacking an mkk4 or mkk7 gene has provided
genetic evidence that MKK4 and MKK7 have nonredundant functions in vivo. To elucidate the physiological
role of MKK4, we generated a novel mouse model in which the mkk4 gene could be specifically deleted in the
brain. At birth, the mutant mice were indistinguishable from their control littermates, but they stopped
growing a few days later and died prematurely, displaying severe neurological defects. Decreased JNK activity
in the absence of MKK4 correlated with impaired phosphorylation of a subset of physiologically relevant JNK
substrates and with altered gene expression. These defects resulted in the misalignment of the Purkinje cells
in the cerebellum and delayed radial migration in the cerebral cortex. Together, our data demonstrate for the
first time that MKK4 is an essential activator of JNK required for the normal development of the brain.
The c-Jun NH2-terminal protein kinase (JNK) (also called
stress-activated protein kinase) is a member of the mitogen-
activated protein kinase (MAPK) family, implicated in the
regulation of numerous cellular functions in response to envi-
ronmental stresses, growth factors, hormones, and proinflam-
matory cytokines (11). Three genes, jnk1, jnk2, and jnk3, en-
coding 10 isoforms, have been cloned. JNK1 and JNK2 are
ubiquitously expressed, while JNK3 is almost exclusively found
in the central nervous system (CNS). To understand the phys-
iological functions of the JNK isoforms in vivo, transgenic mice
deficient in one or more of the jnk genes have been studied
(11). Their phenotypic analysis highlighted the importance of
JNK-mediated apoptosis during the development of the CNS
and in response to brain injury (26, 43, 52). However, apoptosis
does not represent the only functional consequence of JNK
activation. For example, JNK1 appears to contribute to estab-
lishing dendritic architecture in the brain (3, 8, 42).
Analogous to other MAPKs, JNK is activated via the se-
quential activation of protein kinases, which include two dual-
specificity MAPK kinases (MKK4 and MKK7) and multiple
MAPK kinase kinases (MEKKs) (51). The MEKKs phosphor-
ylate and activate MKK4 and MKK7, which, in turn activate
JNK by dual phosphorylation on Thr and Tyr residues within a
Thr-Pro-Tyr motif in protein kinase subdomain VIII (51).
While MKK7 is a specific activator of JNK, MKK4 can also
phosphorylate the Thr-Gly-Tyr motif of the p38 MAPK (50).
Like JNK, p38 MAPK is activated in mammalian cells by
various stress stimuli and proinflammatory cytokines (55).
Physiological evidence for a role of MKK4 in activating the p38
MAPK cascade was recently provided by demonstrating that
decreased expression of MKK4 due to small interfering RNA
in mouse embryonic fibroblasts lacking both MKK3 and
MKK6 suppressed stress-induced p38 MAPK activation (5).
Similar to the early embryonic death caused by the targeted
deletion of both jnk1 and jnk2 genes (26, 43), mice null for
mkk4 or mkk7 die before birth (50). The nonredundant func-
tions of MKK4 and MKK7 in vivo may be due to their distinct
tissue distributions and subcellular localizations. For example,
in neurons, MKK4 is present in both the cell body and the
processes (dendrites and axons), while MKK7 is almost exclu-
sively detected in the nucleus (10). Consequently, MKK4 is
more likely to be critical in maintaining the high basal activity
of JNK in neurites. By enabling JNK to phosphorylate cytosolic
targets, such as microtubule-associated proteins (MAPs),
MKK4 may have a prominent role in mediating the effect of
JNK on dendritic outgrowth and the establishment of func-
tional neural circuits in the brain (3, 8, 42).
To advance our knowledge of the biological function of
MKK4 in the nervous system, we developed a novel mouse
model displaying a specific deletion of the mkk4 gene in the
CNS. Phenotypic analysis of the mice indicated that the dele-
tion of the mkk4 gene affects the normal development of the
brain. Decreased basal JNK activity associated with the ab-
sence of MKK4 causes irregular alignment of Purkinje cells in
the cerebellum and delayed radial migration in the cortex. The
identification of a subset of physiologically relevant substrates
of JNK whose phosphorylation required MKK4 and MKK4
target genes will greatly contribute to unraveling the cell-sig-
naling mechanisms involved during brain development.
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Manchester M13 9PT, United Kingdom. Phone: 44 161 275 5417. Fax:
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MATERIALS AND METHODS
Generation of mkk4-flox mice. The sequence of the mkk4 gene locus was
obtained from GenBank (accession no. AL663069). Gene analysis revealed that
the mkk4 gene is composed of 11 exons and 10 introns. An 8.2-kb BamHI
genomic fragment encompassing exons 3, 4, and 5 of the mkk4 gene was isolated
from an RPCI-21 PAC library (United Kingdom HGMP Resource Centre) and
subcloned into the pBluescript II KS vector (Stratagene). A double-stranded
oligonucleotide containing a SpeI site and a LoxP site was inserted into a SpeI
site created 5 to exon 4, and a loxP-neo-internal ribosome entry site-tk-loxP
cassette was inserted into the EcoRI site 3 of the same exon. This gave rise to
a targeting vector comprising 2.8-kb BamH1-EcoRI and 5.3-kb EcoRI-BamHI
fragments of MKK4-homologous sequences at its 5 and 3 extremity, respec-
tively (Fig. 1). Embryonic stem (ES) cell transfection, selection, and screening
were carried out as described previously (34), using a probe located outside of
the 5 region of the targeting vector (Fig. 1). Three positive clones were retrans-
fected with a Cre-expressing plasmid and counterselected in 1-(2-deoxy-2-fluoro-
-D-arabinofuranosyl)-5-iodouracil (FIAU), and clones that had retained two
loxP sites flanking exon 4 were identified by Southern blotting using a probe
located inside of the targeting vector (Fig. 1). Germ line-transmitting chimeras
were generated. All mice employed for this study were hosted in a pathogen-free
facility at the University of Manchester. The animal studies were carried out
according to Home Office and institutional guidelines.
Genotype determination of mice and tissues. Offspring carrying the mkk4-flox
allele were identified by PCRs on tail DNA using forward (5-GACATTGAGT
TCCT TGCG-3) and reverse (5-TCCTATGTAGTAGGAGTTTG-3) primers.
Fragments (390 bp and 490 bp) were amplified from the wild-type and mkk4-flox
alleles, respectively. The nestin-Cre transgene was identified by PCR as previ-
ously described (18). Genotype determination of tissues was performed by PCR
on genomic DNA using forward (5-TCCTATGTAGTAGGAGTTTG-3) and
reverse (5-GGCAGCTTGTCAGATG-3) primers. Fragments (950 bp and 450
bp) were amplified from the mkk4-flox and disrupted alleles, respectively.
Preparation of lysates. Proteins were extracted from tissues in Triton lysis
buffer (20 mM Tris, pH 7.4, 137 mM NaCl, 2 mM EDTA, 1% Triton X-100,
25 mM -glycerophosphate, 10% glycerol, 1 mM orthovanadate, 1 mM phe-
nylsulfonyl fluoride, 10 g/ml leupeptin, 10 g/ml aprotinin). Extracts were
clarified by centrifugation (14,000  g for 10 min at 4°C). The concentrations
of soluble proteins in the supernatants were quantified by the Bradford
method (Bio-Rad).
Immunoblot analysis. Extracts (20 g) were resolved by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE) (10% or 8% polyacryl-
amide gels) and electrophoretically transferred to Immobilon-P membranes
(Millipore, Inc.). The membranes were incubated with 3% nonfat dry milk at 4°C
for 30 min and probed overnight with antibodies (1:1,000) to MKK4 (BD Phar-
mingen), MKK7 (BD Pharmingen), JNK (Santa Cruz), p38 MAPK (Santa Cruz),
tubulin (Sigma), MAP1B (Santa Cruz), the neurofilament heavy-chain protein
(NF-H) (Sigma), and phosphorylated epitopes of MAP1B and NF-H (Covance;
SMI31). Immune complexes were detected by enhanced chemiluminescence with
anti-mouse or anti-rabbit immunoglobulin G coupled to horseradish peroxidase
as the secondary antibody (Amersham-Pharmacia).
Protein kinase assay. JNK and p38 MAPK activities were measured in lysates
following incubation with glutathione S-transferase (GST)–c-Jun and glutathione-
Sepharose beads or with a polyclonal antibody to p38 MAPK (36) and protein
A agarose beads, respectively, for 2 to 3 h at 4°C. Complexes were washed three
times with Triton lysis buffer and twice with kinase buffer (25 mM HEPES, pH
7.4, 25 mM -glycerophosphate, 25 mM MgCl2, 2 mM dithiothreitol, 0.1%
orthovanadate) prior to being incubated at 30°C for 20 min in kinase buffer
FIG. 1. Strategy for the mutation of the mkk4 gene. (A) The genomic region at the mkk4 locus, the mkk4 targeting vector, and the predicted
structure of the mutated mkk4 gene are depicted. Restriction enzyme sites are indicated (B, BamHI; R, EcoRI; S, SpeI). The black boxes are mkk4
exons. The open box is the neomycin-thymidine kinase cassette (Neo-TK). The black arrowheads indicate the positions of the loxP sites.
(B) Southern blotting analysis of SpeI- and EcoRI-restricted genomic DNA prepared from ES cell clones indicated the presence of all expected
genotypes. The blots were probed with random-primed 32P-labeled mouse MKK4 genomic external and internal probes (gray box in panel A).
(C) Genomic DNAs isolated from brains, hearts, livers, and skeletal muscles (SM) of 1-week-old mice were amplified by PCR with primers specific
for the mkk4 gene. mkk4, mkk4Neo, mkk4f, and mkk4 correspond to the wild-type, mutated, conditional, and knockout alleles, respectively.
ctrl, control; mt, mutant.
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containing 50 M [-32P]ATP (10 Ci/mmol) and 1 g of GST-activating tran-
scription factor 2 (ATF2) for p38 MAPK assays. The reactions were terminated
by the addition of Laemmli sample buffer. Proteins were resolved by SDS-PAGE
and identified by autoradiography. The incorporation of [32P]phosphate was
quantitated by phosphorimager analysis.
Histological and immunohistochemical analyses. Mice were anesthetized and
perfused with 0.9% saline, followed by 4% paraformaldehyde. Their brains were
removed and fixed in 4% paraformaldehyde overnight at 4°C before being
embedded in paraffin. For Nissl staining, 8-m-thick horizontal sections were
stained with 1% cresyl violet (34). For immunohistochemistry, 10-m sagittal
sections were deparaffinized, rehydrated, and treated in boiling sodium citrate
buffer (10 mM, pH 6.0) for 10 min to unmask the antigen. Endogenous perox-
idase activity was quenched by treating the slides with 3% hydrogen peroxidase
for 10 min. Twelve-micrometer horizontal cryosections fixed in ice-cold acetone-
methanol for 20 min were used to detect the neural L1 cell adhesion molecule.
Sections were blocked in phosphate-buffered saline (PBS) containing 10% goat
serum and 0.1% Triton X-100 for 1 h at room temperature prior to being
incubated overnight at 4°C with primary antibodies to MKK4 (1:100; BD Phar-
mingen), phospho-c-Jun (Ser 73) (1:100; Cell Signaling), phospho-ATF2 (Thr
71) (1:100; Cell Signaling), calbindin (1:500; Chemicon), neuronal nuclei (NeuN)
(1:500; Chemicon), myelin basic protein (MBP) (1:100; MAB387; Chemicon),
nestin (1:100; Developmental Studies Hybridoma Bank), nonphosphorylated
epitopes of MAP1B and NF-H (1:500; SMI32; Covance), MAP2 (1:500; Sigma),
and L1 (1:50; MAB5272; Chemicon). The following day, the slides were rinsed in
PBS and incubated at room temperature in the dark for 1 h with secondary goat
anti-mouse, goat anti-rabbit, or donkey anti-rat antibodies conjugated to Alexa
Fluoro 488 (1:500; Invitrogen), Alexa Fluoro 568 (1:500; Invitrogen), or fluores-
cein (1:500; Jackson ImmunoResearch), respectively. The slides were washed
FIG. 2. The disruption of the mkk4 gene significantly reduces JNK activity. (A) Tissue extracts prepared from embryos and mice at various ages
that were homozygous for the mkk4-flox allele and expressed (mutant [mt]) or did not express (control [ctrl]) Cre were analyzed for		4, MKK7,
JNK, and p38 MAPK expression by immunoblot analysis using specific polyclonal antibodies. The detection of tubulin expression was performed
to monitor protein loading. (B) The inactivation of the mkk4 gene in the brains of the mutant mice was confirmed by immunostaining of sagittal
sections of the cerebral cortex, the hippocampus, and the cerebellum at P6 with an antibody to MKK4. (C) Endogenous JNK and p38 MAPK
activities were measured by protein kinase assay (KA) in the presence of [-32P]ATP. The radioactivity incorporated into GST-cJun or GST-ATF2
was quantitated after SDS/PAGE by phosphorimager analysis. The data correspond to the means and standard errors of three independent
experiments. (D) Sagittal sections of different areas of control and mutant brains at P3 or P6 were immunostained with antibodies to phospho-c-Jun
(Ser63) and phospho-ATF2 (Thr71). The results demonstrate that the loss of MKK4 prevents the phosphorylation of c-Jun and ATF2 in the
nervous system.
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three times for 10 min each time in PBS prior to being viewed using the Nikon
Eclipse E600 microscope.
Birth date analysis. Time-mated pregnant mice were injected intraperitoneally
with bromodeoxyuridine (BrdU) (50 g/g body weight) at postcoitum day 11, 13,
14, or 16. The offspring were sacrificed at postnatal day 1 (P1) or P7, and their
brains were processed for paraffin sectioning. Deparaffinized and rehydrated
10-m sagittal sections were treated with 2 N HCl at 60°C for 8 min to denature
DNA and neutralized with 0.1% boric acid buffer, pH 8.5. After being blocked
in PBS containing 5% goat serum, the sections were incubated overnight at 4°C
with a mouse monoclonal anti-BrdU antibody (1:100; Progen). BrdU immuno-
reactivity was detected following incubation of the slides with Alexa Fluoro-
conjugated goat anti-mouse antibody (1:500; Invitrogen). The immunofluores-
cence was detected using a Nikon Eclipse E600 microscope. Fluorescence
intensities inside similar-width rectangles in various regions of the cerebral cor-
tex were quantified with MetaMorph software and expressed as average pixel
densities.
Real-time quantitative PCR. Total RNA was isolated from embryonic day 14
(E14) forebrains using the Trizol reagent, and cDNA synthesis was carried out as
previously described (23). Real-time quantitative PCRs were performed using
the SYBR Green I Core Kit (Eurogentec). (For the sequences of the forward
and reverse primers, see the supplemental material.) PCR products were de-
tected with the ABI-PRISM 7700 sequence detection system (Applied Biosys-
tems). The results were analyzed using the 2

CT method (30). The level of
expression of mRNA was normalized to glyceraldehyde-3-phosphate dehydro-
genase mRNA.
RESULTS
Inactivation of MKK4 in the brain. To make the homozy-
gous mkk4-flox mice, a targeting vector was designed to modify
the mkk4 gene by homologous recombination in ES cells, so
that exon 4 was flanked by loxP sites (Fig. 1A). The loxP sites
do not interfere with the normal expression of the gene but
constitute a binding domain for the DNA recombinase Cre.
Thus, the deletion of the mkk4-flox gene in a particular cell
lineage can be triggered in vivo by crossing the mutant loxP
mice with transgenic animals expressing tissue-specific Cre
(45). An example of a homologous recombined ES cell clone
identified by Southern blotting is shown in Fig. 1B. Chimeric
mice were generated and bred on the C57BL/6 background for
germ line transmission of the mutation. Mice carrying homozy-
gous mkk4-flox alleles were healthy and fertile, confirming that
the presence of two loxP sites did not affect MKK4 function in
vivo.
To inactivate mkk4 in the nervous system, we used a trans-
genic mouse line that expresses Cre under the control of the
nestin promoter (18). The functionality of Cre was tested in
vivo by crossing the nestin-Cre mice with mice carrying a LacZ-
neomycin phosphotransferase (Rosa26 lacZ-loxP) transgene.
In this mouse line, -galactosidase expression is induced fol-
lowing Cre-mediated excision of the loxP-flanked DNA se-
quences in the transgene. Consistent with previous character-
izations of the nestin-Cre mice (18), whole-mount staining
demonstrated that the nestin-Cre line induces efficient recom-
bination in cells that are committed to the neural lineage (data
not shown). Multiple litters of mkk4-flox mice were crossed
with nestin-Cre animals. Amplification by PCR with primers
specific for the mkk4 gene on genomic DNA isolated from
various tissues extracted from 1-week-old mice confirmed the
specific recombination of the mkk4 gene in the brain (Fig. 1C).
Inactivation of MKK4 decreased JNK activity in the ner-
vous system. Immunoblot analysis of brain extracts of litter-
mates homozygous for the mkk4-flox allele and expressing Cre
demonstrated that the inactivation of the mkk4 gene in the
nervous system occurred as early as E14 (Fig. 2A). Reduction
of MKK4 expression in the mutant embryos and mice did not
cause any compensatory changes in the expression of MKK7.
The remaining low level of MKK4 detected was expected, since
MKK4 is likely to be expressed in meningeal cells and blood
vessels, where Cre is not active. Immunostaining of sagittal
sections of the cerebral cortex, hippocampus, and cerebellum
FIG. 3. Mice lacking MKK4 display abnormal growth and motor deficits. (A) Mutant (mt) mice that lack MKK4 in the brain display severe
growth defects, although their weight at birth is indistinguishable from that of control (ctrl) littermates. (B) At P20, the mt mice are notably smaller
than the ctrl littermates and display a reduction in brain size accordingly. (C) MKK4-deficient mice display awkward gait when held by the tail.
(D) The behaviors of mice homozygous for the mkk4-flox allele and harboring a cre transgene under the control of the nestin or the human skeletal
-actin (HSA) promoter were compared. Motor balance and muscular strength were examined by righting reflex and wire hang tests, respectively.
For the righting reflex test, individual mice were placed on their backs and the latency to turning back onto their feet was scored in each case. For
the wire hang test, individual mice were placed on a wire held in an inverted position and the latency to falling off was scored in each case.
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at P6 with an antibody to MKK4 substantiated the absence of
MKK4 in the mutant brain (Fig. 2B). The selective ablation of
mkk4 in the nervous system is demonstrated by similar expres-
sion of MKK4 in the livers, lungs, and hearts of both control
and mutant mice (Fig. 2A).
No marked difference was observed in the expression levels
of JNK and p38 MAPK (Fig. 2A). However, JNK and p38
MAPK activities were decreased by around 80% and 20%,
respectively, following the deletion of the mkk4 gene (Fig. 2C).
Consistent with the requirement for JNK and p38 MAPK to
transcriptionally activate AP-1 factors (53), this resulted in
impaired phosphorylation of c-Jun and ATF2 in the brains of
mice lacking MKK4 (Fig. 2D). The areas examined included
the cerebral cortex, the hippocampus, and the cerebellum at P3
for phosphorylated ATF2 and at P3 or P6 for phosphorylated
c-Jun. Taken together, these results led us to conclude that
MKK4 is a critical activator of JNK in the nervous system.
Phenotypic analysis of MKK4 mutant mice. At birth, the
mutant mice were indistinguishable from their control litter-
mates, but they stopped growing a few days later and generally
died by P21 (Fig. 3A). They became notably smaller by 7 days
postpartum, reaching on average 40% of the weight of sex-
matched littermates at P20 (Fig. 3A and B). The size of the
brain was reduced correspondingly. Between P13 and P15, the
mutant mice displayed striking neurological disorders that in-
cluded ataxia, whole-body tremor, and awkward gait when held
by the tail (Fig. 3C). Decreased motor balance and coordina-
tion were demonstrated by increased latency of the mutant
mice at P14 in turning back onto their feet when placed on
their backs (Fig. 3D, righting reflex). The MKK4-deficient
mice were also five times less able than the control animals to
hold onto a hanging wire (Fig. 3D, wire hang).
To confirm that the abnormal behavior displayed by the
MKK4 mutant mice was not a consequence of muscle wasting,
we tested the effect of mkk4 gene deletion on skeletal muscle.
Mice homozygous for the mkk4-flox allele were crossed with
transgenic mice that expressed Cre under the control of the
human skeletal -actin promoter (46). The specific ablation of
MKK4 in skeletal muscle was verified by immunoblot analysis
(data not shown). The growth curve of the muscle-mutant mice
was indistinguishable from that of their littermates (data not
shown). Although they were slightly less able than the control
mice to hold on to the hanging wire, their righting reflex was
normal (Fig. 3D). Collectively, these behavioral studies clearly
establish that mice carrying a specific deletion of the mkk4
gene in the nervous system display motor deficits due to neu-
rological defects.
Mice that lack MKK4 in the CNS display developmental
defects in the brain. The role of MKK4 in the developing
telencephalon was determined by comparing histological sec-
FIG. 4. The loss of MKK4 affects the organization of the fibers of axons forming the CC and the AC. (A) Sagittal sections of adult brains were
processed by Nissl staining. The fibers of axons forming the AC and the CC in the mutant brain are less fasciculated and appear disorganized and
swollen. (B and C) Sagittal sections of the CC at different embryonic and postnatal stages were stained with antibodies to MBP (B) and L1 (C).
The photographs were taken at different magnifications, as indicated. Scale bars: 10, 100 m; 20, 50 m; 40, 25 m.
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tions of control and mutant brains at P20 (Fig. 4). No marked
differences were detected in the cerebral cortex and the hip-
pocampus. However, the anterior commissure (AC) and the
corpus callosum (CC) in the mutant brain were reduced in
thickness, possibly due to less fasciculated, disorganized axons
(Fig. 4A). This hypothesis was confirmed by immunostaining
saggital sections of the CC at embryonic and postnatal stages
with antibodies to MBP, a marker of oligodendrocytes, and to
L1, a neural-cell adhesion molecule that is primarily expressed
by thalamocortical axons (Fig. 4B and C). In contrast to the
control brain, staining of the thalamic axons lacking MKK4
remained diffused at P20, suggesting that defasciculation of the
cortical afferents had occurred by the third postnatal week
(Fig. 4C).
Similarly, the cerebellum displayed discernible macroscopic
abnormalities in the absence of MKK4 that included a loosely
packed inner granular layer (IGL) and malpositioning of the
Purkinje cells that are normally found aligned beneath (Fig.
5A). The IGL contains the somata of the granule cells that
have migrated inward from the external layer through the
Purkinje cell layer (PCL) (9). The presence of the IGL in the
mutant cerebellum indicated that failure of the Purkinje cells
to form a monolayer did not affect the inward migration of the
granule cells (Fig. 5A). Immunostaining of parasagittal sec-
tions of the cerebellum for calbindin, a well-characterized dif-
ferentiation antigen expressed by Purkinje cells, confirmed that
the PCL was highly disorganized in the mutant brain at P20
and demonstrated that ablation of MKK4 expression did not
cause any dendritic arborization defect (Fig. 5A). In addition,
we found that the size of the Purkinje cells was decreased by
around 25% in the absence of MKK4.
To further characterize the defect in Purkinje cell position-
ing, sagittal sections of the cerebellum were immunostained for
calbindin (red) and NeuN (green) to label Purkinje and gran-
ule cells, respectively, at various postnatal stages (Fig. 5B). In
the control cerebellum, the thick sheet of Purkinje cells con-
stituted at birth had dispersed by P10 into a monolayer that
separated the molecular layer, a cell-poor lamina that contains
the dendrites of the Purkinje cells and the parallel fiber of
axons of the granule cells from the IGL (Fig. 5B). In contrast,
Purkinje cells lacking MKK4 were unable to reorganize, with a
significant number of them misplaced in the IGL by P6 (Fig.
5B). Consistent with the histological analysis of the brain (Fig.
5A), these data demonstrate that the malpositioning of
the Purkinje cells did not prevent the inward migration of the
granule cells.
Birth date analysis. We did not find any evidence that the
loss of MKK4 caused increased apoptosis in the brain (data not
shown). Thus, we explored the possibility that the misplace-
ment of the Purkinje cells in the absence of MKK4 was corre-
lated with birth date abnormalities. In mice, Purkinje cells are
born in the ventricular zone of the cerebellar primordium
between E11 and E13, at which time they exit the cell cycle to
migrate toward the cerebellar plate. Therefore, timed pregnant
females were injected with BrdU 11 and 13 days postcoitum.
The offspring were sacrificed 7 days after birth. Nuclei of Pur-
kinje cells that had incorporated the label while undergoing
cell division at the time of injection were detected by BrdU
FIG. 5. MKK4 is required for the positioning of the Purkinje cells in the cerebellum. (A) Nissl staining of sagittal sections of the adult
cerebellum demonstrates that the Purkinje cells are unable to align beneath the loosely packed IGL. Photographs of the control (ctrl) and mutant
(mt) cerebella were taken at different magnifications, as indicated. The arrows mark the aberrant positions of the Purkinje cells in the brain lacking
MKK4. Immunostaining of parasaggital sections of the cerebellum at P20 with anticalbindin (red) antibody demonstrates that the loss of MKK4
does not interfere with the maturation of the Purkinje cells. (B) Sagittal sections through cerebellar cortices at various ages were double stained
with antibodies against calbindin (red) and NeuN (green) to detect Purkinje cells and granule neurons, respectively. By P10, the sheet of Purkinje
cells, several cells thick, had dispersed into a monolayer in the control (ctrl) but not in the mutant (mt) cerebellum. ML, molecular layer. Scale
bars: 4, 250 m; 10, 100 m; 20, 50 m; 40, 25 m.
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immunoreactivity (Fig. 6). Both early-born (E11) and late-born
(E13) Purkinje cells were found misplaced in the PCL, indi-
cating that the malpositioning of the Purkinje cells was inde-
pendent of their birth dates.
Although the gross anatomy of the mutant cortex showed no
discernible anomaly at P20 (Fig. 4A), a similar analysis was
performed in the cerebral cortex to test whether the absence of
MKK4 affected radial migration, a process known to require
JNK (22). Postmitotic neurons generated in the ventricular
zone migrate radially toward the pial surface following the
typical “inside-out” spatiotemporal sequence (37). Thus, early-
born neurons reside deep in the cortex while those born late
migrate past the existing layers of cells to form the upper
layers. Embryos were labeled in utero with BrdU at the E14 or
at E16 stage of gestation. Control experiments showed that the
wild-type and mutant cells incorporated BrdU labeling to the
same extent (see Fig. S1 in the supplemental material). As
expected in the control mice, early-born neurons (E14) were
found deep in the cortex (layers V and VI) (Fig. 7A and B),
while late-born neurons (E16) were predominantly in the su-
perficial cortex (layers I and II) (Fig. 7C and D). The kinetics
of radial migration was notably different in the absence of
MKK4. In the control mice, the majority of the early-born
neurons (brightly labeled BrdU cells) were positioned in the
lower layers of the cortex at P1, while in the mutant mice, they
were mostly in the upper layers (Fig. 7A, E14 to P1). This
suggested a delay in the radial movement of late-born neurons
(speckled BrdU cells), as they showed an impediment to
migration past the existing deep layers of the cortex. Consistent
with this view, late-born mutant neurons (brightly labeled
BrdU cells) at P1 were still observed in the lower layers while
most of them had already migrated to the upper layers in the
control cortex (Fig. 7C, E16 to P1). Examination of the mutant
cortex at P7 showed that the distributions of both early- and
late-born neurons were comparable to those of controls (Fig.
7B, E14 to P7, and Fig. 7D, E16 to P7). Based on these data,
we concluded that the absence of MKK4 transiently delayed
the radial migration of late-born neurons without affecting the
lamination of the cerebral cortex.
Loss of MKK4 does not affect radial glial-fiber formation.
Migration of postmitotic neurons along radial glial fibers is the
prevalent mode of neuronal movement in the developing
mammalian brain (38). Immunohistochemical analysis of sag-
gital sections of cortices confirmed that early on, the radial
glial cells with elaborated long processes were immunopositive
for nestin, a marker of undifferentiated neuroepithelial cells
(Fig. 8). Parallel fibers that projected radially across the emerg-
ing cortex toward the meninges, where glial endfeet form, were
detected in both the control and the mutant cerebra at embry-
onic and postnatal stages (Fig. 8A). Similarly, the loss of
MKK4 did not prevent the establishment of the Bergmann glia
fascicules, as detected by immunoreactivity against the nestin
antibody at P1 and P3 (Fig. 8B). Collectively, these results
indicated that the absence of MKK4 did not affect the integrity
of the radial glial architecture to support neuronal migration.
In addition, we found that the transmission of the Reelin
signal, which is crucially important for instructing neurons to
move along radial glial fibers (41), was unaffected by the de-
letion of the mkk4 gene (see Fig. S2 in the supplemental
material). Therefore, the migratory defect is most likely a
cell-autonomous effect of the deletion of the mkk4 gene in
neurons.
Identification of target genes downstream of MKK4. To
shed light on the molecular mechanism by which MKK4 affects
neuronal migration and positioning, we performed microarray
analysis using mRNAs isolated from control and mutant E14
embryonic forebrains. This analysis demonstrated that the loss
of MKK4 significantly altered the expression of Rho-activated
kinase (ROCK) and p21-activated kinase (PAK), which are
both involved in the regulation of actin dynamics, such as stress
fiber formation and focal adhesion turnover (1, 4). These
changes were confirmed by real-time PCR experiments (Fig.
9A). The results showed a significant decrease in ROCK1
(60%; P  0.001) and PAK2 (70%; P  0.001), and to a lesser
extent in ROCK2 (35%; P 0.001) and PAK1 (20%; P 0.01),
transcripts in the mutant compared with the control forebrains.
In contrast, MKK4 was not required (P  0.05) for normal
expression of LIM kinases 1 and 2, which stabilize filamentous
actin downstream of ROCK and PAK (13, 31) (Fig. 9A). Sim-
ilarly, expression of focal adhesion kinase, a nonreceptor cy-
toplasmic tyrosine kinase that modulates cell migration in re-
sponse to adhesive interactions between the cell and the
extracellular matrix, was unchanged in the absence of MKK4,
demonstrating the selective effect of mkk4 gene disruption on
FIG. 6. Purkinje cell birth date analysis. Embryos were labeled with
BrdU in utero at E11 and E13 and sacrificed at P7. Early-born (E11)
and late-born (E13) Purkinje cells were detected by immunostaining
them with a BrdU antibody. The arrows mark the BrdU-positive Pur-
kinje cells. Scale bar, 50 m.
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gene expression (data not shown). Consistent with mekk4 gene
deletion (44), loss of MKK4 caused a relatively moderate but
statistically significant (P  0.01) increase in filamin A
(FLN-A) expression (Fig. 9A). In addition, we found that the
expression of kinesin 2 and 2 tubulin, two fundamental com-
ponents of the intracellular transport of organelles (20), was
greatly enhanced in the absence of MKK4 (Fig. 9A).
Phosphorylation of MAP1B and NF-H is impaired in the
absence of MKK4. The microtubule-associated proteins
MAP1B, MAP2, and double cortin (DCX) are essential for
normal brain development (12, 17, 25, 33, 47, 48). Their ability
to control microtubule dynamics is regulated upon phosphor-
ylation by a number of protein kinases, including JNK (3, 8, 16,
22). We found no evidence that MKK4 was implicated in
mediating DCX or MAP2 phosphorylation (see Fig. S3 in the
supplemental material). In contrast, absence of MKK4 almost
completely abolished the phosphorylation of MAP1B (Fig.
9B). This was demonstrated by immunoblot analysis using the
FIG. 7. Absence of MKK4 delays radial migration in the cerebral cortex. Pregnant mice were injected at 14 or 16 days postcoitum, and the
distributions of early-born (E14) (A and B) and late-born (E16) (C and D) neurons in the cerebral cortices of the offspring at P1 (A and C) or
P7 (B and D) were determined by immunostaining them with a BrdU antibody. BrdU immunoreactivity shows the progressive migration of the
early-born neurons from the upper layers toward the deeper layers (V and VI) of the cortex. Conversely, the late-born neurons (E16) were
predominantly found in the superficial cortex (layers I and II). Delayed radial migration in the absence of MKK4 was notable at P1, when most
of the early-born neurons were in the upper layers while late-born neurons had not yet started their migration toward the deeper cortical layers.
The extent of migration was estimated by measuring fluorescence intensities in distinct layers of the cerebral cortex. Intensities relative to the total
fluorescence were calculated and plotted in graphs with standard errors (n  3 animals). *, P  0.01, indicating a significant difference in
fluorescence intensity between control and mutant cortices. Scale bar, 50 m.
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SMI31 antibody, which detects the phosphorylated MAP1B
isoform, which displays reduced microtubule-stabilizing activ-
ity, only in the control extracts. A pan-anti-MAP1B antibody
(N19) revealed that the level of MAP1B expression was unaf-
fected by the loss of MKK4 (Fig. 9B). We concluded that
MKK4-mediated MAP1B phosphorylation was likely to be
part of the mechanism by which MKK4 reduces microtubule
stabilization to promote cell motility.
Similarly, SMI31 was unable to detect the phosphorylated
form of NF-H in the mutant samples (Fig. 9B). This correlated
with a strong immunoreactivity of the Purkinje cells and of
neurons in layer V in the mutant cortices against SMI32, an
antibody that specifically recognizes the nonphosphorylated
epitope of NF-H (Fig. 9C). The defective phosphorylation of
NF-H in brain extracts lacking MKK4 was further confirmed
by the absence of an electrophoretic migratory shift of the
protein analyzed by SDS-PAGE using a monoclonal antibody
(N52) that detects both the hypo- and hyperphosphorylated
forms of NF-H (Fig. 9B). Together, these results provide
strong genetic evidence that MKK4 is required for mediating
NF-H phosphorylation.
DISCUSSION
Overall, this study has increased our understanding of the
physiological function of the JNK signaling pathway by allow-
ing the functional effect of loss of JNK activation to be exam-
ined as opposed to loss of expression. The requirement for
MKK4 to activate JNK in the nervous system can be explained
by the distinct specificity of MKK4 and MKK7 for the Tyr and
Thr residues within the T-X-Y motif of JNK (15, 28, 29).
Consequently, both activators might be required to induce
maximal activation of JNK. Alternatively, MKK4 may be the
main JNK activator in the brain during development. Indeed,
the overall level of expression of mkk4 mRNA in the embryo
is much higher than that of mkk7, which is found mainly in
epithelial tissues (35, 54). Furthermore, we found that MKK7
expression is lower in embryonic than in postnatal stage. The
analysis of the effect of the targeted deletion of the mkk7 gene
in the CNS will be essential to distinguish between these two
possibilities and to clarify whether MKK4 and MKK7 have
distinct functions in the brain during embryogenesis. In addi-
tion, we found that p38 MAPK activity was reduced in the
absence of MKK4. This is consistent with the physiological role
of MKK4 in mediating p38 MAPK activation in response to
stress (5).
Impaired JNK activity caused by mkk4 gene deletion was not
correlated with the defect in neuronal apoptosis and exen-
cephaly displayed by the jnk1/ jnk2/ mice (26, 43) or with
the loss of telencephalic commissures, as observed in the brains
of the jnk1/ and jip3/ mice (8, 24). Instead, the fibers
forming the CC and the AC appeared swollen and defascicu-
lated. A reduction in the thickness of the CC and AC was
previously observed in the cerebra of embryos lacking the dual
leucine zipper kinase (DLK), a member of the mixed-lineage
kinases that function as a MEKK in the JNK signaling pathway
(19). Furthermore, similar to the effect of mkk4 gene disrup-
tion, the loss of DLK resulted in delayed neural-cell migration
(19). However, in contrast to jnk1 (3, 8) or dlk gene deletion
(19), the disruption of the mkk4 gene did not affect the phos-
phorylation of MAP2. We also found no difference in the
phosphorylation of DCX in the brain in the embryonic or
postnatal stage at three consensus sites for JNK (16, 19). Thus,
although the regulation of MKK4 by DLK may constitute an
important signaling pathway that contributes to the develop-
ment of the telencephalon, it is possible that the loss of MKK4
and DLK selectively affects different JNK isoforms. Conse-
quently, the remaining 20% of JNK activity in the MKK4
mutant brain may be sufficient for triggering the phosphoryla-
tion of a subset of JNK substrates displaying high affinity for
JNK1.
The most striking phenotypic abnormality displayed by the
brain-specific mkk4/ mice was the inability of the Purkinje
cells to organize in the typical linear position at the molecular
layer-IGL boundary. Purkinje cells are the primary integrative
neurons of the cerebellar cortex and provide its sole output
(49). As a result, alteration in the PCL is often associated with
FIG. 8. The loss of MKK4 does not affect the architecture of the
radial glial fibers. Sagittal sections of control (ctrl) and mutant (mt)
cortices at various embryonic and postnatal stages were immuno-
stained with antibodies to nestin to visualize radial glial fibers. The
radial glia in the cerebra (A) and in the cerebella (B) of both genotypes
formed a regular network with fibers extending through the cortical
plate to the meningeal-cell layer. Scale bars: 20, 50 m; 40, 25 m.
VOL. 27, 2007 NOVEL ROLE OF MKK4 DURING BRAIN DEVELOPMENT 7943
functional lesions of the cerebellum. Since the cerebellum acts
as a coordination center using sensory inputs from the periph-
ery to fine tune movement and balance (21), the defect in
Purkinje cell positioning is likely to be the cause of the motor
deficits displayed by the mutant animals. In addition to coor-
dinating motion, MKK4 may also be involved in the higher
cognitive functions of the cerebellum, such as motor learning
(21). Overall, we conclude that the cerebellar defect associated
with the loss of MKK4 is likely to be responsible for the early
demise of the mutant mice.
To shed light on the biochemical mechanisms that account
for the phenotypic abnormalities caused by MKK4 ablation, we
searched for physiologically relevant substrates of JNK whose
phosphorylation required MKK4. Consistent with the ability of
MKK4 to activate JNK in both the cell body and processes of
neurons (10), we found that the phosphorylation of both nu-
FIG. 9. Identification of downstream targets of MKK4. (A) Total RNAs were extracted from control (ctrl) and mutant (mt) E14 embryonic
forebrains, and the amounts of various transcripts were measured by quantitative real-time PCR. The data are expressed relative (n-fold) to the
mRNA extracted from the control brain and correspond to the means and standard errors of three independent experiments performed in
triplicate. P values relative to the control sample are indicated by asterisks: ***, P  0.001; **, P  0.01; *, P  0.05. (B) Phosphorylation of
MAP1B and NF-H was examined by immunoblot analysis of brain extracts (20 g) using antibodies against the phosphorylated forms of MAP1B
and NF-H (SMI31). Absence of MKK4 was correlated with a specific defect in MAP1B and NF-H phosphorylation. Pan-antibodies to MAP1B
(N19) and NF-H (N52) showed no significant difference in the expression levels of the proteins between the two genotypes. Note that the detection
of phospho-NF-H (P-NF-H) by SMI31 in control extracts was correlated with the retarded mobility of the protein after SDS-PAGE. Similar results
were obtained in two independent experiments. (C) Consistent with the defective phosphorylation of NF-H in the mutant extracts, cerebellar
and cerebral cortices lacking MKK4 displayed strong immunoreactivity against SMI32, an antibody that specifically reacts with the
nonphosphorylated form of NF-H. No difference was observed in the immunostaining of the control and mutant cortices with the anti-MAP2
antibody. Scale bar, 50 m.
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clear (c-Jun and ATF2) and cytosolic (MAP1B and NF-H)
targets of JNK was impaired in the absence of MKK4. It is
unlikely that the defect in c-Jun phosphorylation contributes to
the abnormal phenotype of the MKK4 mutant mice because
mutational removal of the JNK phosphorylation sites in c-Jun
causes no obvious brain-developmental defect (2). In contrast,
similar misplacement of Purkinje cells has been observed in the
cerebella of atf2-, and map1B-deficient mice (17, 40). This
suggests that MKK4-induced ATF2 and MAP1B phosphory-
lation by JNK may be critical for the organization of the PCL
into a monolayer beneath the IGL.
The defective phosphorylation of MAP1B, together with
abnormal gene regulation in the absence of MKK4, may also
be responsible for delayed radial migration in the cerebral
cortex. This is strongly supported by JNK-dependent phosphor-
ylation of MAP1B, which leads to microtubule stabilization in
migrating neurons (22), and by excess expression of FLN-A,
which inhibits neuronal migration caused by mekk4 gene de-
letion (44). The moderate increase in FLN-A expression in the
absence of MKK4 is consistent with a delay rather than a block
in cell motility. The down-regulation of ROCK and PAK in the
mutant E14 embryonic forebrains may also contribute to the
migration defect by affecting actin dynamics and subsequently
the formation of stress fibers and focal adhesions (1, 4). In
addition, reduced expression of ROCK may account in part for
the effects of mkk4 gene disruption on the development of the
telencephalic commissures, since altered Rho signaling causes
defects in the morphogenesis of commissural neurons (6, 7).
Increased expression of kinesin-2 and 2 tubulin in the ab-
sence of MKK4 would be expected to affect the intracellular
transport of organelles in axons and cellular morphology,
which can also influence cell locomotion (20).
In contrast to MAP1B, very little is known about the func-
tional effect of NF-H phosphorylation. NF-H is one of the five
major types of intermediate filament proteins expressed in
mature neurons (27). It is found heavily phosphorylated on its
carboxy-terminal tail domain in axons. This was originally
thought to be involved in determining axonal caliber (32).
However, this suggestion was recently disputed by the pheno-
typic analysis of mice with targeted deletion of the C-terminal
domain containing all of the phosphorylation sites (39). Alter-
natively, NF-H, together with MAP1B, may be required for the
proper dendritic arborization of neurons, a process known to
be controlled by JNK (3, 27, 42). This is consistent with the
maximum phosphorylation of NF-H and MAP1B at a time
(P10) when dendrites are actively formed in the cerebrum. An
understanding of the implication of MKK4-dependent phos-
phorylation of NF-H and MAP1B in dendritic development
may provide crucial information on how functional neural cir-
cuits in the brain are established. These results may also be
relevant to increasing our knowledge of the role of JNK in
neurodegenerative diseases associated with abnormal phos-
phorylation of NF-H, such as diabetic neuropathy (14).
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